(no change within 30 days of enrolling) with parents agreeing to avoid medication changes during time of study participation Ability to tolerate actigraphy and parental willingness to complete sleep diary Family primary language English Actigraphy results, mean ± SD Sleep latency, minutes, G1: 59.8 ± 31.6 G2: 56.0 ± 25.2 Sleep efficiency, % G1: 76.2 ± 6.2 G2: 76.4 ± 8.0 WASO, min G1: 63.8 ± 28.4 G2: 60.4 ± 22.1 Total sleep time, min G1: 486.9 ± 48 G2: 482.4 ± 56.7 Sleep latency, minutes, mean ± SD G1: 39.5 ± 21.6 G2: 39.7 ± 21.5 G1 vs G2: p=0.63 Sleep efficiency, % G1: 78.7 ± 5.1 G2: 79.8 ± 6.0 G1 vs G2: p=0.56 WASO, min G1: 59.3 ± 27.3 G2: 58.3 ± 23.7 G1 vs G2: p=0.37 Total sleep time, min G1: 481.1 ± 49.5 G2: 488.3 ± 50.3 G1 vs G2: p=0.37 Harms NR Modifiers NR C-22 stable during treatment: Yes Concomitant therapies, n (%): Medication type Psychotropic G1: 7 (15) G2: 6 (18) Melatonin G1: 7 (15) G2: 5 (15) Stimulants G1: 8 (17) G2: 6 (18) N at enrollment: G1+ G2: 114 N at follow-up: G1: 47 G2: 33 Screening by developmental pediatrician to identify medical and behavioral comorbidities that affect sleep (see below) Exclusion criteria: children with untreated comorbidities that affect sleep including sleep apnea, epilepsy, gastrointestinal reflux disease, and depression were not enrolled in study until after co-occurring conditions were addressed. Age, mean years ± SD: G1: 5.6 ± 2.6 G2: 5.9 ± 2.8 Mental age: IQ >70, n (%): G1: 27 (64%) G2: 15 (45%) Sex: M, n (%) G1: 39 (83) G2: 25 (76) F, n (%) G 1: 8 (17) G2: (8 (24) Race/ethnicity, n (%): White G1: 37 (80) G2: 26 (84) SES: C-23 Hollingshead Four - Factor Index, mean ± SD: G1: 44.3 ± 13.5 G2: 44.7 ± 10.6 Diagnostic approach: In Study Diagnostic tool/method: DSM_IV-TR, ADOS Diagnostic category, n (%): Autism G1: 32 (68) G2: 26 (79) PDD-NOS G1: 4 (8.5) G2: 2 (6) Asperger syndrome G1: 11 (23.4) G2: 5 (15) Other characteristics, n (%): NR Comments: The Children’s Sleep Habits Questionnaire and Behavior and Family Questionnaire results are presented for both groups combined. C-24 Table C-1. Evidence table, continued Study Description Intervention Inclusion/ Exclusion Criteria/ Population Baseline Measures Outcomes Author: Mandelberg et al. 2013 7 Country: US Intervention setting: Home & school Enrollment period: average of 43.2 months after initial intervention (2004- 2008) Funding: National Institute of Mental Health, NICHD, NIDCD and NINDS Design: RCT Note: See study reporting on this population 8 in 2011 AHRQ review 9 Intervention: UCLA Children’s Friendship Training (CFT) Program mode, with 12 weekly hour-long sessions involving separate groups for children and parents; children with other diagnoses were included as peer models Assessments: parent and child report Groups: G1: CFT Provider: Psychologist L.C.S.W. Undergraduate psychology students Treatment manual followed: Yes Defined protocol followed: Yes Measure of treatment fidelity reported: Yes Co-interventions held stable during treatment: NR Inclusion criteria: Attending